177 related articles for article (PubMed ID: 30786962)
1. Prognostic significance of positive circumferential resection margin post neoadjuvant chemotherapy in patients with esophageal or gastro-esophageal junction adenocarcinoma.
Patrão AS; Papaxoinis G; Kordatou Z; Weaver JM; Owen-Holt V; Alkhaffaf B; Galloway S; Mansoor W
Eur J Surg Oncol; 2019 Mar; 45(3):439-445. PubMed ID: 30786962
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
Depypere L; Moons J; Lerut T; De Hertogh G; Peters C; Sagaert X; Coosemans W; Van Veer H; Nafteux P
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036407
[TBL] [Abstract][Full Text] [Related]
3. The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study.
Papaxoinis G; Kamposioras K; Weaver JMJ; Kordatou Z; Stamatopoulou S; Germetaki T; Nasralla M; Owen-Holt V; Anthoney A; Mansoor W
J Gastrointest Surg; 2019 Sep; 23(9):1729-1741. PubMed ID: 30671799
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
[TBL] [Abstract][Full Text] [Related]
5. Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route.
Scheepers JJ; van der Peet DL; Veenhof AA; Cuesta MA
Dis Esophagus; 2009; 22(1):42-8. PubMed ID: 19196265
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
[TBL] [Abstract][Full Text] [Related]
7. Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma.
van der Sluis PC; Ubink I; van der Horst S; Boonstra JJ; Voest EE; Ruurda JP; Borel Rinkes IH; Wiezer MJ; Schipper ME; Siersema PD; Los M; Lolkema MP; van Hillegersberg R
Ann Surg Oncol; 2015 May; 22(5):1555-63. PubMed ID: 25564156
[TBL] [Abstract][Full Text] [Related]
8. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of circumferential resection margin involvement in patients receiving potentially curative treatment for oesophageal cancer.
Quinn LM; Hollis AC; Hodson J; Elshafie MA; Hallissey MT; Whiting JL; Griffiths EA
Eur J Surg Oncol; 2018 Aug; 44(8):1268-1277. PubMed ID: 29843937
[TBL] [Abstract][Full Text] [Related]
10. Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study.
Bissolati M; Desio M; Rosa F; Rausei S; Marrelli D; Baiocchi GL; De Manzoni G; Chiari D; Guarneri G; Pacelli F; De Franco L; Molfino S; Cipollari C; Orsenigo E
Gastric Cancer; 2017 Jan; 20(1):70-82. PubMed ID: 26732876
[TBL] [Abstract][Full Text] [Related]
11. Minimally Invasive Circumferential Hiatal Dissection for the Treatment of Adenocarcinoma of the Distal Esophagus and Esophago-gastric Junction: Technical Considerations Combined With Histopathological Outcomes.
Lorenzi B; Davakis S; Syllaios A; Kordzadeh A; Kadri M; Ram M; Fareed K; Barter C; Charalabopoulos A
Anticancer Res; 2019 Jun; 39(6):3219-3225. PubMed ID: 31177171
[TBL] [Abstract][Full Text] [Related]
12. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
[TBL] [Abstract][Full Text] [Related]
13. Tumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junction.
Mingol F; Gallego J; Orduña A; Martinez-Blasco A; Sola-Vera J; Moya P; Morcillo MA; Ruiz JA; Calpena R; Lacueva FJ
BMC Surg; 2015 May; 15():66. PubMed ID: 25997454
[TBL] [Abstract][Full Text] [Related]
14. Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus.
Knight WRC; Yip C; Wulaningsih W; Jacques A; Griffin N; Zylstra J; Van Hemelrijck M; Maisey N; Gaya A; Baker CR; Kelly M; Gossage JA; Lagergren J; Landau D; Goh V; Davies AR; ; Ngan S; Qureshi A; Deere H; Green M; Chang F; Mahadeva U; Gill-Barman B; George S; Dunn J; Zeki S; Meenan J; Hynes O; Tham G; Iezzi C
BJS Open; 2019 Dec; 3(6):767-776. PubMed ID: 31832583
[TBL] [Abstract][Full Text] [Related]
15. [Endoscopic marking of upper tumor resection margin and lymphatic drainage before neoadjuvant chemotherapy in Siewert type II adenocarcinoma of esophagogastric junction].
Cao YH; Zhang JL; Ma PF; Liu CY; Li S; Zhang XJ; Han GS; Zhao YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):819-822. PubMed ID: 34530564
[No Abstract] [Full Text] [Related]
16. Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
Springfeld C; Wiecha C; Kunzmann R; Heger U; Weichert W; Langer R; Stange A; Blank S; Sisic L; Schmidt T; Lordick F; Jäger D; Grenacher L; Bruckner T; Büchler MW; Ott K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S905-14. PubMed ID: 26001861
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
[TBL] [Abstract][Full Text] [Related]
18. Curative resection for adenocarcinoma of the gastro-esophageal junction following neo-adjuvant chemotherapy-thoraco-abdominal vs. trans-abdominal approach.
Kumar NA; Desouza A; Bhandare MS; Murugan JR; Khandelwal G; Chaudhari V; Ostwal V; Shrikhande SV
Langenbecks Arch Surg; 2021 May; 406(3):613-621. PubMed ID: 33242137
[TBL] [Abstract][Full Text] [Related]
19. Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment.
O'Neill JR; Stephens NA; Save V; Kamel HM; Phillips HA; Driscoll PJ; Paterson-Brown S
Br J Surg; 2013 Jul; 100(8):1055-63. PubMed ID: 23616367
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significant or Not? The Positive Circumferential Resection Margin in Esophageal Cancer: Impact on Local Recurrence and Overall Survival in Patients Without Neoadjuvant Treatment.
Ghadban T; Reeh M; Koenig AM; Nentwich MF; Bellon E; Izbicki JR; Vashist YK; Kutup A
Ann Surg; 2017 Dec; 266(6):988-994. PubMed ID: 27617855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
